Global Recombinant Human Follicle-stimulating Hormone Market Professional Survey Report 2016
- QYR596782
- 107 Pages
- June 2016
- Pharmaceuticals
Product types including
Injection
Freeze-dried powder
The segment applications including
Hospital use
Clinic use
Household
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono Europe Ltd
Ortho Biotech
Roche
Abcam
NCPC
Merck (Schweiz) AG
Changchun GenSci
3SBio Inc
Uni-Bio Science Group Limited
With 13 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Recombinant Human Follicle-stimulating Hormone
1.1 Definition and Specifications of Recombinant Human Follicle-stimulating Hormone
1.1.1 Definition of Recombinant Human Follicle-stimulating Hormone
1.1.2 Specifications of Recombinant Human Follicle-stimulating Hormone
1.2 Classification of Recombinant Human Follicle-stimulating Hormone
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Applications of Recombinant Human Follicle-stimulating Hormone
1.3.1 Hospital use
1.3.2 Clinic use
1.3.3 Household
1.4 Industry Chain Structure of Recombinant Human Follicle-stimulating Hormone
1.5 Industry Overview and Major Regions Status of Recombinant Human Follicle-stimulating Hormone
1.5.1 Industry Overview of Recombinant Human Follicle-stimulating Hormone
1.5.2 Global Major Regions Status of Recombinant Human Follicle-stimulating Hormone
1.6 Industry Policy Analysis of Recombinant Human Follicle-stimulating Hormone
1.7 Industry News Analysis of Recombinant Human Follicle-stimulating Hormone
2 Manufacturing Cost Structure Analysis of Recombinant Human Follicle-stimulating Hormone
2.1 Raw Material Suppliers and Price Analysis of Recombinant Human Follicle-stimulating Hormone
2.2 Equipment Suppliers and Price Analysis of Recombinant Human Follicle-stimulating Hormone
2.3 Labor Cost Analysis of Recombinant Human Follicle-stimulating Hormone
2.4 Other Costs Analysis of Recombinant Human Follicle-stimulating Hormone
2.5 Manufacturing Cost Structure Analysis of Recombinant Human Follicle-stimulating Hormone
2.6 Manufacturing Process Analysis of Recombinant Human Follicle-stimulating Hormone
3 Technical Data and Manufacturing Plants Analysis of Recombinant Human Follicle-stimulating Hormone
3.1 Capacity and Commercial Production Date of Global Recombinant Human Follicle-stimulating Hormone Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Recombinant Human Follicle-stimulating Hormone Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Recombinant Human Follicle-stimulating Hormone Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Recombinant Human Follicle-stimulating Hormone Major Manufacturers in 2015
4 Global Recombinant Human Follicle-stimulating Hormone Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Recombinant Human Follicle-stimulating Hormone Capacity and Growth Rate Analysis
4.2.2 2015 Recombinant Human Follicle-stimulating Hormone Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate Analysis
4.3.2 2015 Recombinant Human Follicle-stimulating Hormone Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Recombinant Human Follicle-stimulating Hormone Sales Price
4.4.2 2015 Recombinant Human Follicle-stimulating Hormone Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Recombinant Human Follicle-stimulating Hormone Gross Margin
4.5.2 2015 Recombinant Human Follicle-stimulating Hormone Gross Margin Analysis (Company Segment)
5 Recombinant Human Follicle-stimulating Hormone Regional Market Analysis
5.1 North America Recombinant Human Follicle-stimulating Hormone Market Analysis
5.1.1 North America Recombinant Human Follicle-stimulating Hormone Market Overview
5.1.2 North America 2011-2016E Recombinant Human Follicle-stimulating Hormone Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Recombinant Human Follicle-stimulating Hormone Sales Price Analysis
5.1.4 North America 2015 Recombinant Human Follicle-stimulating Hormone Market Share Analysis
5.2 Europe Recombinant Human Follicle-stimulating Hormone Market Analysis
5.2.1 Europe Recombinant Human Follicle-stimulating Hormone Market Overview
5.2.2 Europe 2011-2016E Recombinant Human Follicle-stimulating Hormone Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Recombinant Human Follicle-stimulating Hormone Sales Price Analysis
5.2.4 Europe 2015 Recombinant Human Follicle-stimulating Hormone Market Share Analysis
5.3 Japan Recombinant Human Follicle-stimulating Hormone Market Analysis
5.3.1 Japan Recombinant Human Follicle-stimulating Hormone Market Overview
5.3.2 Japan 2011-2016E Recombinant Human Follicle-stimulating Hormone Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Recombinant Human Follicle-stimulating Hormone Sales Price Analysis
5.3.4 Japan 2015 Recombinant Human Follicle-stimulating Hormone Market Share Analysis
5.4 China Recombinant Human Follicle-stimulating Hormone Market Analysis
5.4.1 China Recombinant Human Follicle-stimulating Hormone Market Overview
5.4.2 China 2011-2016E Recombinant Human Follicle-stimulating Hormone Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Recombinant Human Follicle-stimulating Hormone Sales Price Analysis
5.4.4 China 2015 Recombinant Human Follicle-stimulating Hormone Market Share Analysis
5.5 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Analysis
5.5.1 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Overview
5.5.2 Southeast Asia 2011-2016E Recombinant Human Follicle-stimulating Hormone Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Recombinant Human Follicle-stimulating Hormone Sales Price Analysis
5.5.4 Southeast Asia 2015 Recombinant Human Follicle-stimulating Hormone Market Share Analysis
5.6 India Recombinant Human Follicle-stimulating Hormone Market Analysis
5.6.1 India Recombinant Human Follicle-stimulating Hormone Market Overview
5.6.2 India 2011-2016E Recombinant Human Follicle-stimulating Hormone Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Recombinant Human Follicle-stimulating Hormone Sales Price Analysis
5.6.4 India 2015 Recombinant Human Follicle-stimulating Hormone Market Share Analysis
6 Global 2011-2016E Recombinant Human Follicle-stimulating Hormone Segment Market Analysis (by Type)
6.1 Global 2011-2016E Recombinant Human Follicle-stimulating Hormone Sales by Type
6.2 Different Types Recombinant Human Follicle-stimulating Hormone Product Interview Price Analysis
6.3 Different Types Recombinant Human Follicle-stimulating Hormone Product Driving Factors Analysis
6.3.1 Injection Recombinant Human Follicle-stimulating Hormone Growth Driving Factor Analysis
6.3.2 Freeze-dried powder Recombinant Human Follicle-stimulating Hormone Growth Driving Factor Analysis
7 Global 2011-2016E Recombinant Human Follicle-stimulating Hormone Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Recombinant Human Follicle-stimulating Hormone Growth Driving Factor Analysis
7.3.2 Clinic use Recombinant Human Follicle-stimulating Hormone Growth Driving Factor Analysis
7.3.3 Household Recombinant Human Follicle-stimulating Hormone Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Recombinant Human Follicle-stimulating Hormone
8.1 Novo Nordisk
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Novo Nordisk 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Novo Nordisk 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Amgen 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Amgen 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.3 Sanofi
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Sanofi 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Sanofi 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.4 Eli Lilly
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Eli Lilly 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Eli Lilly 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.5 Merck Serono Europe Ltd
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Merck Serono Europe Ltd 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merck Serono Europe Ltd 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.6 Ortho Biotech
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Ortho Biotech 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Ortho Biotech 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.7 Roche
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Roche 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Roche 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.8 Abcam
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Abcam 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Abcam 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.9 NCPC
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 NCPC 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 NCPC 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.10 Merck (Schweiz) AG
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Merck (Schweiz) AG 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Merck (Schweiz) AG 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.11 Changchun GenSci
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Changchun GenSci 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Changchun GenSci 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.12 3SBio Inc
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 3SBio Inc 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 3SBio Inc 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
8.13 Uni-Bio Science Group Limited
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Uni-Bio Science Group Limited 2015 Recombinant Human Follicle-stimulating Hormone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Uni-Bio Science Group Limited 2015 Recombinant Human Follicle-stimulating Hormone Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Recombinant Human Follicle-stimulating Hormone Consumption Forecast
9.2.2 Europe 2016-2021 Recombinant Human Follicle-stimulating Hormone Consumption Forecast
9.2.3 Japan 2016-2021 Recombinant Human Follicle-stimulating Hormone Consumption Forecast
9.2.4 China 2016-2021 Recombinant Human Follicle-stimulating Hormone Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Recombinant Human Follicle-stimulating Hormone Consumption Forecast
9.2.6 India 2016-2021 Recombinant Human Follicle-stimulating Hormone Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Recombinant Human Follicle-stimulating Hormone Marketing Model Analysis
10.1 Recombinant Human Follicle-stimulating Hormone Regional Marketing Model Analysis
10.2 Recombinant Human Follicle-stimulating Hormone International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Recombinant Human Follicle-stimulating Hormone by Regions
10.4 Recombinant Human Follicle-stimulating Hormone Supply Chain Analysis
11 Consumers Analysis of Recombinant Human Follicle-stimulating Hormone
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Recombinant Human Follicle-stimulating Hormone
12.1 New Project SWOT Analysis of Recombinant Human Follicle-stimulating Hormone
12.2 New Project Investment Feasibility Analysis of Recombinant Human Follicle-stimulating Hormone
13 Conclusion of the Global Recombinant Human Follicle-stimulating Hormone Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
